Baxter Bros Inc’s Bausch Health BHC Stock Holding History

Baxter Bros Inc’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-9,675	Closed	-$221K	–	122
2022 Q1	$221K	Buy	9,675 +1,200	+14%	+$29.3K	0.03%	119
2021 Q4	$234K	Hold	8,475	–	–	0.03%	118
2021 Q3	$236K	Hold	8,475	–	–	0.04%	118
2021 Q2	$248K	Sell	8,475 -150	-2%	-$4.54K	0.04%	116
2021 Q1	$274K	Sell	8,625 -2,000	-19%	-$58.7K	0.05%	111
2020 Q4	$221K	Hold	10,625	–	–	0.04%	113
2020 Q3	$165K	Sell	10,625 -75	-0.7%	-$1.29K	0.04%	111
2020 Q2	$196K	Sell	10,700 -2,000	-16%	-$35.2K	0.05%	112
2020 Q1	$197K	Sell	12,700 -200	-2%	-$4.82K	0.05%	106
2019 Q4	$386K	Sell	12,900 -2,000	-13%	-$52K	0.08%	97
2019 Q3	$326K	Hold	14,900	–	–	0.07%	92
2019 Q2	$376K	Hold	14,900	–	–	0.09%	92
2019 Q1	$368K	Hold	14,900	–	–	0.09%	91
2018 Q4	$275K	Sell	14,900 -1,000	-6%	-$23.8K	0.07%	97
2018 Q3	$408K	Buy	+15,900	New	+$364K	0.1%	92

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Baxter Bros Inc's BHC Position: Q2 2022 in Review

Baxter Bros Inc sold out of Bausch Health (BHC) in Q2 2022, closing a stake of 9,675 shares — an estimated $221K sold.

Baxter Bros Inc first reported a position in BHC in Q3 2018 and held it in 15 quarters. The position peaked at $408K in Q3 2018. 327 funds tracked by Wall St. Rank hold BHC as of Q2 2022.

Baxter Bros Inc reported no remaining Bausch Health position as of Q2 2022 after selling out during the quarter.
Baxter Bros Inc sold 9,675 Bausch Health shares in Q2 2022, an estimated $221K.
Baxter Bros Inc first reported a position in Bausch Health in Q3 2018 and held it in 15 quarters.
Baxter Bros Inc's Bausch Health position peaked at $408K in Q3 2018.
327 funds tracked by Wall St. Rank held Bausch Health as of Q2 2022.

Based on Baxter Bros Inc's 13F filing for Q2 2022, filed 25 Jul 2022.